Home | All trials

[RDF data]
Trial NCT00000343

Resource URI: http://static.linkedct.org/resource/trials/NCT00000343
PropertyValue
linkedct:brief_title Brain Changes in Stimulant Dependent Subjects - 8
linkedct:condition <http://static.linkedct.org/resource/condition/12664>
linkedct:criteria Inclusion Criteria: M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.
linkedct:description By Incorporating QEEG into clinical trails, the plan is to develop physiologic markers of treatment efficacy, and to aid in the identification of effective treatments.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 50 Years
linkedct:eligibility_minimum_age 21 Years
linkedct:enrollment 90 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000343
rdfs:label Trial NCT00000343
linkedct:lastchanged_date June 23, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/209856>
linkedct:nct_id NCT00000343
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Brain Changes in Stimulant Dependent Subjects
linkedct:org_study_id NIDA-3-0010-8
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/60742>
linkedct:overall_status Active, not recruiting
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000343>
linkedct:phase Phase 4
linkedct:secondary_id Y01-3-0010-8
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date April 1996
linkedct:study_design Treatment
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to identify the neurophysiologic indicators of cocaine or methamphetamine use and withdrawal, to examine the relationship between subjects' reports of depression, craving, and stimulant use, and neurophysiologic measures, and to identify neurophysiologic measures which can be used to identify new treatments for stimulant dependence.
rdf:type linkedct:trials
linkedct:verification_date April 1996